Joint Venture (Tables)

6 Months Ended

Mar. 31, 2025

Equity Method Investments and Joint Ventures [Abstract]

Unamortized Deferred Revenue from JV

Unamortized deferred revenue from material rights in connection with the JV formation included:

	March 31, 2025		September 30, 2024
Accrued liabilities	$	6,939	$	6,580
Other liabilities		234,069		232,164

Other Income Related JV

Other income related to Woodward’s equity interest in the earnings of the JV was as follows:

	Three Months Ended March 31,				Six Months Ended March 31,
	2025		2024		2025		2024
Other income	$	11,386	$	8,701	$	21,542	$	18,856

Cash Distribution from JV

Cash distributions to Woodward from the JV, recognized in “Other, net” in “Net cash provided by operating activities” on the Condensed Consolidated Statements of Cash Flows, were as follows:

	Three Months Ended March 31,				Six Months Ended March 31,
	2025		2024		2025		2024
Cash distributions	$	10,000	$	12,000	$	21,000	$	18,500

Net Sales to the JV

Net sales to the JV were as follows:

	Three Months Ended March 31,				Six Months Ended March 31,
	2025		2024		2025		2024
Net sales	$	24,270	$	22,080	$	44,966	$	42,352

Accounts Receivable, Accounts Payable, and Other Assets Related to JV

The Condensed Consolidated Balance Sheets include “Accounts receivable” related to amounts the JV owed Woodward, “Accounts payable” related to amounts Woodward owed the JV, and “Other assets” related to Woodward’s net investment in the JV, as follows:

	March 31, 2025		September 30, 2024
Accounts receivable	$	5,729	$	5,205
Accounts payable		6,129		11,378
Other assets		19,761		19,219